Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Cristhian Manuel Durán-Acevedo, Aylen Lisset Jaimes-Mogollón, Oscar Eduardo Gualdrón-Guerrero, Tesfalem Geremariam Welearegay, Julián DavÃd Martinez-MarÃn, Juan MartÃn Caceres-Tarazona, Zayda Constanza Sánchez-Acevedo, Kelvin de Jesus Beleño-Saenz, Umut Cindemir, Lars Österlund, Radu Ionescu
Published Jun 22, 2018 · Vol. 9, No. 48 · pp. 28805-28817
Aya Maeda, Yuki Nishida, Marla Weetall, Liangxian Cao, Arthur Branstrom, Jo Ishizawa, Takenobu Nii, Wendy D. Schober, Yoshiaki Abe, Kosei Matsue, Mariko Yoshimura, Shinya Kimura, Kensuke Kojima
Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28547-28560
Pornima Phatak, Whitney M. Burrows, Ingrid E. Chesnick, Mohan E. Tulapurkar, Jaladanki N. Rao, Douglas J. Turner, Anne W. Hamburger, Jian-Ying Wang, James M. Donahue
Published Jun 19, 2018 · Vol. 9, No. 47 · pp. 28391-28407